within Pharmacolibrary.Drugs.ATC.C;

model C01BA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.93,
    Cl             = 7.833333333333333e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0011,
    Tlag           = 690.0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01BA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sparteine is a naturally occurring alkaloid formerly used as an antiarrhythmic agent (class 1a) for heart rhythm disorders. It has also been studied as an oxytocic agent. Sparteine is not currently approved or widely used in modern clinical practice due to safety concerns and the availability of safer alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, both sexes. Oral administration.</p><h4>References</h4><ol><li><p>Aasmundstad, TA, et al., &amp; Mørland, J (1995). Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose. <i>British journal of clinical pharmacology</i> 39(6) 611–620. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1995.tb05720.x&quot;>10.1111/j.1365-2125.1995.tb05720.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7654478/&quot;>https://pubmed.ncbi.nlm.nih.gov/7654478</a></p></li><li><p>Damkier, P, et al., &amp; Brøsen, K (1999). Effect of fluvoxamine on the pharmacokinetics of quinidine. <i>European journal of clinical pharmacology</i> 55(6) 451–456. DOI:<a href=&quot;https://doi.org/10.1007/s002280050655&quot;>10.1007/s002280050655</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10492058/&quot;>https://pubmed.ncbi.nlm.nih.gov/10492058</a></p></li><li><p>Persson, K, et al., &amp; Rane, A (1992). The postoperative pharmacokinetics of codeine. <i>European journal of clinical pharmacology</i> 42(6) 663–666. DOI:<a href=&quot;https://doi.org/10.1007/BF00265933&quot;>10.1007/BF00265933</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1623909/&quot;>https://pubmed.ncbi.nlm.nih.gov/1623909</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01BA04;
